Chenguang Biotech Group (SHE:300138) — Market Cap & Net Worth

$776.91 Million USD  · CN¥5.31 Billion CNY  · Rank #10115

Market Cap & Net Worth: Chenguang Biotech Group (300138)

Chenguang Biotech Group (SHE:300138) has a market capitalization of $776.91 Million (CN¥5.31 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #10115 globally and #2683 in its home market, demonstrating a -5.67% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chenguang Biotech Group's stock price CN¥10.99 by its total outstanding shares 483100093 (483.10 Million). Also see Chenguang Biotech Group asset portfolio for a full breakdown of the balance sheet.

Chenguang Biotech Group Market Cap History: 2015 to 2026

Chenguang Biotech Group's market capitalization history from 2015 to 2026. Data shows growth from $537.94 Million to $776.91 Million (6.08% CAGR). Also see Chenguang Biotech Group cash flow conversion for how efficiently the company converts equity into cash flow.

Chenguang Biotech Group Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Chenguang Biotech Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Chenguang Biotech Group (300138) share price today for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.09x

Chenguang Biotech Group's market cap is 0.09 times its annual revenue

Industry average: 0.31x Lower than industry average

Latest Price to Earnings (P/E) Ratio

6.55x

Chenguang Biotech Group's market cap is 6.55 times its annual earnings

Industry average: 17.46x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $537.94 Million $1.27 Billion $68.86 Million 0.42x 7.81x
2016 $553.69 Million $2.14 Billion $92.47 Million 0.26x 5.99x
2017 $541.51 Million $2.77 Billion $142.83 Million 0.20x 3.79x
2018 $347.08 Million $3.06 Billion $145.28 Million 0.11x 2.39x
2019 $506.28 Million $3.27 Billion $193.57 Million 0.16x 2.62x
2020 $1.30 Billion $3.91 Billion $267.74 Million 0.33x 4.86x
2021 $1.14 Billion $4.87 Billion $351.51 Million 0.23x 3.25x
2022 $1.22 Billion $6.30 Billion $434.03 Million 0.19x 2.82x
2023 $935.24 Million $6.87 Billion $479.72 Million 0.14x 1.95x
2024 $616.44 Million $6.99 Billion $94.05 Million 0.09x 6.55x

Competitor Companies of 300138 by Market Capitalization

Companies near Chenguang Biotech Group in the global market cap rankings as of September 19, 2026. Review Chenguang Biotech Group tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Chenguang Biotech Group by market ranking:

  • Archer-Daniels-Midland Company (NYSE:ADM): Ranked #821 globally with a market cap of $33.40 Billion USD.
  • Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #825 globally with a market cap of $33.05 Billion USD ( CN¥225.89 Billion CNY).
  • Bunge Limited (NYSE:BG): Ranked #1169 globally with a market cap of $22.37 Billion USD.
  • Tyson Foods Inc (NYSE:TSN): Ranked #1648 globally with a market cap of $14.87 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#821 Archer-Daniels-Midland Company NYSE:ADM $33.40 Billion $85.18
#825 Muyuan Foodstuff Co Ltd SHE:002714 $33.05 Billion CN¥41.35
#1169 Bunge Limited NYSE:BG $22.37 Billion $115.58
#1648 Tyson Foods Inc NYSE:TSN $14.87 Billion $52.77

Chenguang Biotech Group Historical Marketcap From 2015 to 2026

Between 2015 and today, Chenguang Biotech Group's market cap moved from $537.94 Million to $ 776.91 Million, with a yearly change of 6.08%.

Year Market Cap Change (%)
2026 CN¥776.91 Million -11.44%
2025 CN¥877.30 Million +42.32%
2024 CN¥616.44 Million -34.09%
2023 CN¥935.24 Million -23.57%
2022 CN¥1.22 Billion +7.03%
2021 CN¥1.14 Billion -12.20%
2020 CN¥1.30 Billion +157.18%
2019 CN¥506.28 Million +45.87%
2018 CN¥347.08 Million -35.90%
2017 CN¥541.51 Million -2.20%
2016 CN¥553.69 Million +2.93%
2015 CN¥537.94 Million --

End of Day Market Cap According to Different Sources

On Sep 19th, 2026 the market cap of Chenguang Biotech Group was reported to be:

Source Market Cap
Yahoo Finance $776.91 Million USD
MoneyControl $776.91 Million USD
MarketWatch $776.91 Million USD
marketcap.company $776.91 Million USD
Reuters $776.91 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Chenguang Biotech Group

SHE:300138 China Farm Products
Market Cap
$776.91 Million
CN¥5.31 Billion CNY
Market Cap Rank
#10115 Global
#2683 in China
Share Price
CN¥10.99
Change (1 day)
-1.26%
52-Week Range
CN¥8.94 - CN¥15.71
All Time High
CN¥19.02
About

ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more